Innovation: Early detection and treatment of coronary artery disease before a heart attack
Tracks
Track 9
| Friday, August 7, 2026 |
| 1:45 PM - 3:15 PM |
Speaker
Suzanne Avis
Estimated global burden of silent coronary artery disease - health and ecomonic implications and opportunities
1:45 PM - 1:55 PMBiography
Prof Filippo Crea
Director Center of Excellence in Cardiovascular Sciences
Gemelli Isola Tiberina Hospital
Evidence-based shift in the guidelines regarding treatment of patients with silent CAD
1:55 PM - 2:05 PMBiography
Prof. Filippo Crea, FESC, was born in Cosenza, Italy on 19 September 1953. He graduated from Pisa Medical School with full honours in 1977 and passed the Postgraduate Boards in both Pulmonary and Cardiovascular Diseases, again with full honours, at Pisa Medical School in 1980 and 1983 respectively. During the whole of 1984 he was Research Fellow at the Division of Cardiology of the University of Florida, directed by Professor Richard C. Conti. From 1985 to 1991 he was Senior Lecturer and Honorary Consultant at the Cardiovascular Research Unit of the Hammersmith Hospital in London, directed by Professor Attilio Maseri. He returned to Italy upon his appointment as Chief of the Catheterization Laboratory at the Institute of Cardiology of the Catholic University of Rome. In 2000 he became Associate Professor of Cardiology and Chief of the Intensive and Sub-Intensive Care Unit. In 2001 he became Professor of Cardiology, Director of the Institute of Cardiology, Director of the Postgraduate School in Cardiology and of the PhD program in Clinical Research in Cellular and Molecular Medicine at the Catholic University of Rome. From October 2008 to January 2020 he was Director of the Department of Cardiovascular Sciences. From February 2020 to October 2023 he was Director of the University Department of Cardiovascular and Pneumological Sciences. Since November 2023 he is Director of the Centre of Excellence in Cardiovascular Medicine at the Gemelli-Isola Tiberina Hospital. He is Fellow of the European Society of Cardiology, founder and Past Chairman of the Working Group on Coronary Pathophysiology and Microcirculation, Past Member of the Education Committee, Past Member of the ESC Congress Program Committee, co-author of Guidelines on chronic coronary syndromes (2013), NSTEMI (2017), UDMI (2019). Since 2020 he is Editor-in-Chief of the “European Heart Journal” and since 2022 Chairman of ESC Publications Committee. In 1992 he received from Nobel Prize Professor Rita Levi Montalcini the Newburg Prize for his scientific contribution to the cardiovascular research. In 2013 he received the Arrigo Recordati International Prize for lifetime achievement in researching the pivotal role of microcirculation in systemic and organ diseases. In 2015 he delivered the 7th annual Robert L. Krakoff International Lecture in Cardiovascular Medicine at the Brigham and Women’s Hospital, Harvard University Medical School. His main field of interest is the study of mechanisms, prevention, diagnosis and treatment of ischemic heart disease. He is the author of more than 1500 publications in peer reviewed journals with an H-Index of 95.
Dr Ron Blankstein
Brigham and Women's Hospital / Harvard University
Non-invasive imaging technology for screening and risk stratification of silent CAD
2:05 PM - 2:15 PMBiography
Dr. Ron Blankstein is the Associate Director of the Cardiovascular Imaging Program, Director of Cardiac Computed Tomography, and a preventative cardiology specialist at Brigham and Women’s Hospital (BWH). In addition, he is a Professor of Medicine at Harvard Medical School (HMS).
Dr. Blankstein is the immediate Past-President of the Society of Cardiovascular Computed Tomography and serves on the Board of Directors of the American Society of Preventive Cardiology. He received his medical degree from Rush Medical College. He completed an internal medicine residency and a cardiology fellowship at the University of Chicago Medical Center. Dr. Blankstein then completed an advanced fellowship in cardiac imaging at Massachusetts General Hospital. He is certified in cardiovascular disease, nuclear cardiology, and cardiovascular computed tomography.
His clinical interests focus on methods to identify and treat early stages of coronary heart disease, prevention of cardiovascular disease, and diagnosis and treatment of cardiac sarcoidosis. Dr. Blankstein is an expert in the use of multi-modality imaging for the assessment of cardiovascular disease. This includes acquiring and interpreting non-invasive cardiovascular imaging tests—such as cardiac MRI, cardiac CT, nuclear cardiology, and exercise treadmill testing. The author of over 400 publications, Dr. Blankstein’s research compares the results of different imaging techniques as well as the impact of these tests on the patient management and outcomes. Dr. Blankstein frequently lectures on topics ranging from preventive cardiology and risk assessment to how to use the results of cardiovascular imaging in patient management decisions.
Prof Stuart M Grieve
Professor, Team Lead
University of Sydney / Sydney Translational Imaging Laboratory
Photon counting CCTA - a game changer
2:15 PM - 2:25 PMBiography
Assoc Prof Abdul Rahman Ihdayhid
Cardiologist
Fiona Stanley Hospital
Advanced image analysis of plaque and implications for personalised heart attack prevention
2:25 PM - 2:35 PMBiography
Abdul-Rahman Ihdayhid is an Interventional Cardiologist and Cardiac CT Specialist. Director of Cardiologist Research at Fiona Stanley Hospital. Interest in cardiac CT and computational modelling in coronary and structural interventions.
Prof Ray Mahoney
Consideration of equity and scale - an Indigenous Australian perspective
2:35 PM - 2:45 PMBiography
Prof Christian Hamilton-Craig
Director, Noosa Hearts Cardiology
University of Queensland
MSAC application for CACS - and a rethink of Australian guidelines to prevent widening of the gap
2:45 PM - 2:55 PMBiography
Prof Christian Hamilton-Craig multi-modality imaging cardiologist. Professor of Medicine University of Queensland & Griffith University .
He is the chief guideline writer for the CSANZ Position Statement on Coronary Artery Calcium Scoring. He he has published over 150 scientific papers including citations in the AHA/ACC Valve Guidelines. He collects guitars and likes to surf.
Dr Sina Fathieh
Cardiology Trainee
The University of Sydney
Novel biomarkers to triage screening for silent CAD - reducing the number needed to scan to address the challenge of scale
2:55 PM - 3:05 PMBiography
